Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2013

01.05.2013 | Epidemiology

Radial scars and subsequent breast cancer risk: results from the Nurses’ Health Studies

verfasst von: Sarah A. Aroner, Laura C. Collins, James L. Connolly, Graham A. Colditz, Stuart J. Schnitt, Bernard A. Rosner, Susan E. Hankinson, Rulla M. Tamimi

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Radial scars (RS) are benign proliferative lesions associated with an increased risk of subsequent breast cancer. However, it remains unclear whether RS are an independent risk factor for breast cancer or whether their association with breast cancer is due to their common occurrence with other proliferative lesions known to increase breast cancer risk. We performed an updated analysis of the association between RS and subsequent breast cancer risk in a nested case–control study among 460 cases and 1,792 controls with benign breast disease (BBD) in the Nurses’ Health Studies. Logistic regression was used to estimate associations between RS in BBD biopsy specimens and breast cancer risk, adjusted for matching factors and breast cancer risk factors, including histologic category of concurrent BBD. In multivariable models prior to adjustment for histologic category of BBD, RS were associated with a twofold increased risk of breast cancer (odds ratio (OR) = 2.0; 95 % confidence interval (95 % CI) 1.4, 2.8). This association was attenuated but still significant after adjustment for BBD histologic category (OR = 1.6; 95 % CI 1.1, 2.3). In models adjusted for BBD histologic category and other covariates, risk appeared greater among women with multiple RS (1 RS, OR = 1.5; 95 % CI 0.9, 2.3; ≥2 RS, OR = 2.7; 95 % CI 1.5, 5.0; p-heterogeneity = 0.12). There were also suggestions of a greater risk associated with RS among women age ≥50 years at biopsy (p-heterogeneity = 0.07) and for estrogen receptor-negative/progesterone receptor-negative tumors compared with other hormone receptor subtypes (p-heterogeneity = 0.19). RS appear to be an independent histologic risk factor for breast cancer. Larger studies are needed to further evaluate whether risk is increased when multiple RS are present and whether associations vary by age at biopsy or by hormone receptor status of the breast tumor.
Literatur
1.
Zurück zum Zitat Page DL, Dupont WD (1992) Benign breast disease: indicators of increased breast cancer risk. Cancer Detect Prev 16(2):93–97PubMed Page DL, Dupont WD (1992) Benign breast disease: indicators of increased breast cancer risk. Cancer Detect Prev 16(2):93–97PubMed
2.
Zurück zum Zitat London SJ, Connolly JL, Schnitt SJ, Colditz GA (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267(7):941–944PubMedCrossRef London SJ, Connolly JL, Schnitt SJ, Colditz GA (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267(7):941–944PubMedCrossRef
3.
Zurück zum Zitat Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353(3):229–237. doi:10.1056/NEJMoa044383 PubMedCrossRef Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353(3):229–237. doi:10.​1056/​NEJMoa044383 PubMedCrossRef
4.
Zurück zum Zitat Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71(4):1258–1265PubMedCrossRef Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71(4):1258–1265PubMedCrossRef
5.
Zurück zum Zitat Wellings SR, Alpers CE (1984) Subgross pathologic features and incidence of radial scars in the breast. Hum Pathol 15(5):475–479PubMedCrossRef Wellings SR, Alpers CE (1984) Subgross pathologic features and incidence of radial scars in the breast. Hum Pathol 15(5):475–479PubMedCrossRef
6.
Zurück zum Zitat Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ (1999) Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 340(6):430–436PubMedCrossRef Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ (1999) Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 340(6):430–436PubMedCrossRef
7.
Zurück zum Zitat Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD (2006) Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer 106(7):1453–1461. doi:10.1002/cncr.21730 PubMedCrossRef Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD (2006) Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer 106(7):1453–1461. doi:10.​1002/​cncr.​21730 PubMedCrossRef
8.
Zurück zum Zitat Berg JC, Visscher DW, Vierkant RA, Pankratz VS, Maloney SD, Lewis JT, Frost MH, Ghosh K, Degnim AC, Brandt KR, Vachon CM, Reynolds CA, Hartmann LC (2008) Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat 108(2):167–174PubMedCrossRef Berg JC, Visscher DW, Vierkant RA, Pankratz VS, Maloney SD, Lewis JT, Frost MH, Ghosh K, Degnim AC, Brandt KR, Vachon CM, Reynolds CA, Hartmann LC (2008) Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat 108(2):167–174PubMedCrossRef
9.
Zurück zum Zitat Manfrin E, Remo A, Falsirollo F, Reghellin D, Bonetti F (2008) Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases. Breast Cancer Res Treat 107(3):371–377PubMedCrossRef Manfrin E, Remo A, Falsirollo F, Reghellin D, Bonetti F (2008) Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases. Breast Cancer Res Treat 107(3):371–377PubMedCrossRef
10.
Zurück zum Zitat Linell F, Ljungberg O, Andersson I (1980) Breast carcinoma. Aspects of early stages, progression and related problems. Acta Pathol Microbiol Scand Suppl 272:1–233PubMed Linell F, Ljungberg O, Andersson I (1980) Breast carcinoma. Aspects of early stages, progression and related problems. Acta Pathol Microbiol Scand Suppl 272:1–233PubMed
11.
Zurück zum Zitat Fisher ER, Palekar AS, Kotwal N, Lipana N (1979) A nonencapsulated sclerosing lesion of the breast. Am J Clin Pathol 71(3):240–246PubMed Fisher ER, Palekar AS, Kotwal N, Lipana N (1979) A nonencapsulated sclerosing lesion of the breast. Am J Clin Pathol 71(3):240–246PubMed
12.
Zurück zum Zitat Vega A, Mosquera J, Delgado A, Sogo C, Ortega E, Garijo F, Alvarez A (2000) Proliferative changes in nonpalpable breast lesions detected by mammography. Radiologia 42(5):299–304 Vega A, Mosquera J, Delgado A, Sogo C, Ortega E, Garijo F, Alvarez A (2000) Proliferative changes in nonpalpable breast lesions detected by mammography. Radiologia 42(5):299–304
13.
Zurück zum Zitat Douglas-Jones AG, Pace DP (1997) Pathology of R4 spiculated lesions in the breast screening programme. Histopathology 30(3):214–220PubMedCrossRef Douglas-Jones AG, Pace DP (1997) Pathology of R4 spiculated lesions in the breast screening programme. Histopathology 30(3):214–220PubMedCrossRef
14.
Zurück zum Zitat Sloane JP, Mayers MM (1993) Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 23(3):225–231PubMedCrossRef Sloane JP, Mayers MM (1993) Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 23(3):225–231PubMedCrossRef
15.
Zurück zum Zitat Frouge C, Tristant H, Guinebretiere JM, Meunier M, Contesso G, Di Paola R, Blery M (1995) Mammographic lesions suggestive of radial scars: microscopic findings in 40 cases. Radiology 195(3):623–625PubMed Frouge C, Tristant H, Guinebretiere JM, Meunier M, Contesso G, Di Paola R, Blery M (1995) Mammographic lesions suggestive of radial scars: microscopic findings in 40 cases. Radiology 195(3):623–625PubMed
16.
Zurück zum Zitat Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2007) Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the nurses’ health study. Cancer 109(2):180–187. doi:10.1002/cncr.22408 PubMedCrossRef Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2007) Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the nurses’ health study. Cancer 109(2):180–187. doi:10.​1002/​cncr.​22408 PubMedCrossRef
17.
Zurück zum Zitat Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2006) The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the nurses’ health study. Cancer 107(6):1240–1247. doi:10.1002/cncr.22136 PubMedCrossRef Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2006) The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the nurses’ health study. Cancer 107(6):1240–1247. doi:10.​1002/​cncr.​22136 PubMedCrossRef
18.
Zurück zum Zitat Schnitt SJ, Connolly JL (2004) Pathology of benign breast disorders. In: Harris JR, Lippman ME, Morrow M, Osborne CK (eds) Diseases of the breast, 3rd edn. Lipincott Williams & Wilkins, Philadelphia, pp 69–86 Schnitt SJ, Connolly JL (2004) Pathology of benign breast disorders. In: Harris JR, Lippman ME, Morrow M, Osborne CK (eds) Diseases of the breast, 3rd edn. Lipincott Williams & Wilkins, Philadelphia, pp 69–86
19.
Zurück zum Zitat Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55(11):2698–2708PubMedCrossRef Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55(11):2698–2708PubMedCrossRef
20.
Zurück zum Zitat Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, Colditz GA (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6(5):297–301PubMed Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, Colditz GA (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6(5):297–301PubMed
21.
Zurück zum Zitat Tamimi RM, Baer HJ, Marotti J, Galan M, Galaburda L, Fu Y, Deitz AC, Connolly JL, Schnitt SJ, Colditz GA, Collins LC (2008) Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res 10(4):R67. doi:10.1186/bcr2128 PubMedCrossRef Tamimi RM, Baer HJ, Marotti J, Galan M, Galaburda L, Fu Y, Deitz AC, Connolly JL, Schnitt SJ, Colditz GA, Collins LC (2008) Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res 10(4):R67. doi:10.​1186/​bcr2128 PubMedCrossRef
22.
Zurück zum Zitat Collins LC, Marotti JD, Baer HJ, Tamimi RM (2008) Comparison of estrogen receptor results from pathology reports with results from central laboratory testing. J Natl Cancer Inst 100(3):218–221. doi:10.1093/jnci/djm270 PubMedCrossRef Collins LC, Marotti JD, Baer HJ, Tamimi RM (2008) Comparison of estrogen receptor results from pathology reports with results from central laboratory testing. J Natl Cancer Inst 100(3):218–221. doi:10.​1093/​jnci/​djm270 PubMedCrossRef
23.
Zurück zum Zitat Mokbel K, Price RK, Carpenter R (1999) Radial scars and breast cancer. N Engl J Med 341(3):210PubMed Mokbel K, Price RK, Carpenter R (1999) Radial scars and breast cancer. N Engl J Med 341(3):210PubMed
24.
Zurück zum Zitat de la Torre M, Wells AF, Bergh J, Lindgren A (1993) Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma. Hum Pathol 24(12):1294–1297PubMedCrossRef de la Torre M, Wells AF, Bergh J, Lindgren A (1993) Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma. Hum Pathol 24(12):1294–1297PubMedCrossRef
25.
Zurück zum Zitat Iqbal M, Shoker BS, Foster CS, Jarvis C, Sibson DR, Davies MPA (2002) Molecular and genetic abnormalities in radial scar. Hum Pathol 33(7):715–722PubMedCrossRef Iqbal M, Shoker BS, Foster CS, Jarvis C, Sibson DR, Davies MPA (2002) Molecular and genetic abnormalities in radial scar. Hum Pathol 33(7):715–722PubMedCrossRef
26.
Zurück zum Zitat Jacobs TW, Schnitt SJ, Tan X, Brown LF (2002) Radial scars of the breast and breast carcinomas have similar alterations in expression of factors involved in vascular stroma formation. Hum Pathol 33(1):29–38PubMedCrossRef Jacobs TW, Schnitt SJ, Tan X, Brown LF (2002) Radial scars of the breast and breast carcinomas have similar alterations in expression of factors involved in vascular stroma formation. Hum Pathol 33(1):29–38PubMedCrossRef
27.
Zurück zum Zitat Bissell MJ, Weaver VM, Lelievre SA, Wang F, Petersen OW, Schmeichel KL (1999) Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res 59(7 Suppl):1757s–1763s (discussion 1763s–1764s) Bissell MJ, Weaver VM, Lelievre SA, Wang F, Petersen OW, Schmeichel KL (1999) Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res 59(7 Suppl):1757s–1763s (discussion 1763s–1764s)
28.
Zurück zum Zitat Hansen RK, Bissell MJ (2000) Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. Endocr Relat Cancer 7(2):95–113PubMedCrossRef Hansen RK, Bissell MJ (2000) Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. Endocr Relat Cancer 7(2):95–113PubMedCrossRef
29.
Zurück zum Zitat Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, Lupu R, Bissell MJ (1998) Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA 95(25):14821–14826PubMedCrossRef Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, Lupu R, Bissell MJ (1998) Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA 95(25):14821–14826PubMedCrossRef
30.
Zurück zum Zitat Ronnov-Jessen L, Petersen OW, Bissell MJ (1996) Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76(1):69–125PubMed Ronnov-Jessen L, Petersen OW, Bissell MJ (1996) Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76(1):69–125PubMed
32.
Zurück zum Zitat Vega A, Garijo F (1993) Radial scar and tubular carcinoma. Mammographic and sonographic findings. Acta Radiol 34(1):43–47PubMed Vega A, Garijo F (1993) Radial scar and tubular carcinoma. Mammographic and sonographic findings. Acta Radiol 34(1):43–47PubMed
33.
Zurück zum Zitat Cabral AH, Recine M, Paramo JC, McPhee MM, Poppiti R, Mesko TW (2003) Tubular carcinoma of the breast: an institutional experience and review of the literature. Breast J 9(4):298–301PubMedCrossRef Cabral AH, Recine M, Paramo JC, McPhee MM, Poppiti R, Mesko TW (2003) Tubular carcinoma of the breast: an institutional experience and review of the literature. Breast J 9(4):298–301PubMedCrossRef
34.
Zurück zum Zitat Sullivan T, Raad RA, Goldberg S, Assaad SI, Gadd M, Smith BL, Powell SN, Taghian AG (2005) Tubular carcinoma of the breast: a retrospective analysis and review of the literature. Breast Cancer Res Treat 93(3):199–205. doi:10.1007/s10549-005-5089-7 PubMedCrossRef Sullivan T, Raad RA, Goldberg S, Assaad SI, Gadd M, Smith BL, Powell SN, Taghian AG (2005) Tubular carcinoma of the breast: a retrospective analysis and review of the literature. Breast Cancer Res Treat 93(3):199–205. doi:10.​1007/​s10549-005-5089-7 PubMedCrossRef
Metadaten
Titel
Radial scars and subsequent breast cancer risk: results from the Nurses’ Health Studies
verfasst von
Sarah A. Aroner
Laura C. Collins
James L. Connolly
Graham A. Colditz
Stuart J. Schnitt
Bernard A. Rosner
Susan E. Hankinson
Rulla M. Tamimi
Publikationsdatum
01.05.2013
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2013
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2535-9

Weitere Artikel der Ausgabe 1/2013

Breast Cancer Research and Treatment 1/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.